Harvard Apparatus Regenerative Technology Inc.
HRGN
$2.18
-$0.17-7.40%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 83.19% | 3.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 83.19% | 3.20% | |||
| Cost of Revenue | 89.81% | 3.52% | |||
| Gross Profit | 15.00% | 0.00% | |||
| SG&A Expenses | -28.29% | 5.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.96% | -4.43% | |||
| Operating Income | -5.35% | 5.42% | |||
| Income Before Tax | -5.87% | 5.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.87% | 5.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.87% | 5.10% | |||
| EBIT | -5.35% | 5.42% | |||
| EBITDA | -5.36% | 5.42% | |||
| EPS Basic | -5.82% | 7.23% | |||
| Normalized Basic EPS | -5.98% | 7.33% | |||
| EPS Diluted | -5.82% | 7.23% | |||
| Normalized Diluted EPS | -5.98% | 7.33% | |||
| Average Basic Shares Outstanding | 0.00% | 2.30% | |||
| Average Diluted Shares Outstanding | 0.00% | 2.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||